Pharma Reviews: Kiran Mazumdar-Shaw silences Twitter trolls with a 78% Biocon stock rally

But, the rest of India's pharmaceutical industry remains sceptical. While the country's mastery over low-cost copies of simple chemical medicines has ...
Read more: Kiran Mazumdar-Shaw silences Twitter trolls with a 78% Biocon stock rally